Global Gene Therapy in CNS Disorder Market Growth (Status and Outlook) 2026-2032

April 2026 | 79 pages | ID: G89AA062CDC5EN
LP Information

Abstracts

The global Gene Therapy in CNS Disorder market size is predicted to grow from US$ 748 million in 2025 to US$ 2061 million in 2032; it is expected to grow at a CAGR of 15.9% from 2026 to 2032.

Gene therapy entails the specific transfer of genetic information into affected cells and tissues in order to restore function in diseased areas.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the ?Gene Therapy in CNS Disorder Industry Forecast? looks at past sales and reviews total world Gene Therapy in CNS Disorder sales in 2025, providing a comprehensive analysis by region and market sector of projected Gene Therapy in CNS Disorder sales for 2026 through 2032. With Gene Therapy in CNS Disorder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy in CNS Disorder industry.

This Insight Report provides a comprehensive analysis of the global Gene Therapy in CNS Disorder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Therapy in CNS Disorder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Gene Therapy in CNS Disorder market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy in CNS Disorder and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy in CNS Disorder.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy in CNS Disorder market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Viral Gene Therapy
• Non-viral Gene Therapy

Segmentation by Application:

• Alzheimer's Disease
• Huntington's Disease
• Parkinson's Disease
• Batten Disease

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Voyager Therapeutics
• Spark Therapeutics
• Novartis AG
• Bluebird Bio Inc.
• Biogen

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Gene Therapy in CNS Disorder Market Size (2021-2032)
  2.1.2 Gene Therapy in CNS Disorder Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Gene Therapy in CNS Disorder by Country/Region (2021, 2025 & 2032)
2.2 Gene Therapy in CNS Disorder Segment by Type
  2.2.1 Viral Gene Therapy
  2.2.2 Non-viral Gene Therapy
  2.2.3 Gene Therapy in CNS Disorder Market Size by Type
    2.2.3.1 Gene Therapy in CNS Disorder Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global Gene Therapy in CNS Disorder Market Size Market Share by Type (2021-2026)
2.3 Gene Therapy in CNS Disorder Segment by Application
  2.3.1 Alzheimer's Disease
  2.3.2 Huntington's Disease
  2.3.3 Parkinson's Disease
  2.3.4 Batten Disease
  2.3.5 Gene Therapy in CNS Disorder Market Size by Application
    2.3.5.1 Gene Therapy in CNS Disorder Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.5.2 Global Gene Therapy in CNS Disorder Market Size Market Share by Application (2021-2026)

3 GENE THERAPY IN CNS DISORDER MARKET SIZE BY PLAYER

3.1 Gene Therapy in CNS Disorder Market Size Market Share by Player
  3.1.1 Global Gene Therapy in CNS Disorder Revenue by Player (2021-2026)
  3.1.2 Global Gene Therapy in CNS Disorder Revenue Market Share by Player (2021-2026)
3.2 Global Gene Therapy in CNS Disorder Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 GENE THERAPY IN CNS DISORDER BY REGION

4.1 Gene Therapy in CNS Disorder Market Size by Region (2021-2026)
4.2 Global Gene Therapy in CNS Disorder Annual Revenue by Country/Region (2021-2026)
4.3 Americas Gene Therapy in CNS Disorder Market Size Growth (2021-2026)
4.4 APAC Gene Therapy in CNS Disorder Market Size Growth (2021-2026)
4.5 Europe Gene Therapy in CNS Disorder Market Size Growth (2021-2026)
4.6 Middle East & Africa Gene Therapy in CNS Disorder Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Gene Therapy in CNS Disorder Market Size by Country (2021-2026)
5.2 Americas Gene Therapy in CNS Disorder Market Size by Type (2021-2026)
5.3 Americas Gene Therapy in CNS Disorder Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Gene Therapy in CNS Disorder Market Size by Region (2021-2026)
6.2 APAC Gene Therapy in CNS Disorder Market Size by Type (2021-2026)
6.3 APAC Gene Therapy in CNS Disorder Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Gene Therapy in CNS Disorder Market Size by Country (2021-2026)
7.2 Europe Gene Therapy in CNS Disorder Market Size by Type (2021-2026)
7.3 Europe Gene Therapy in CNS Disorder Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Gene Therapy in CNS Disorder by Region (2021-2026)
8.2 Middle East & Africa Gene Therapy in CNS Disorder Market Size by Type (2021-2026)
8.3 Middle East & Africa Gene Therapy in CNS Disorder Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL GENE THERAPY IN CNS DISORDER MARKET FORECAST

10.1 Global Gene Therapy in CNS Disorder Forecast by Region (2027-2032)
  10.1.1 Global Gene Therapy in CNS Disorder Forecast by Region (2027-2032)
  10.1.2 Americas Gene Therapy in CNS Disorder Forecast
  10.1.3 APAC Gene Therapy in CNS Disorder Forecast
  10.1.4 Europe Gene Therapy in CNS Disorder Forecast
  10.1.5 Middle East & Africa Gene Therapy in CNS Disorder Forecast
10.2 Americas Gene Therapy in CNS Disorder Forecast by Country (2027-2032)
  10.2.1 United States Market Gene Therapy in CNS Disorder Forecast
  10.2.2 Canada Market Gene Therapy in CNS Disorder Forecast
  10.2.3 Mexico Market Gene Therapy in CNS Disorder Forecast
  10.2.4 Brazil Market Gene Therapy in CNS Disorder Forecast
10.3 APAC Gene Therapy in CNS Disorder Forecast by Region (2027-2032)
  10.3.1 China Gene Therapy in CNS Disorder Market Forecast
  10.3.2 Japan Market Gene Therapy in CNS Disorder Forecast
  10.3.3 Korea Market Gene Therapy in CNS Disorder Forecast
  10.3.4 Southeast Asia Market Gene Therapy in CNS Disorder Forecast
  10.3.5 India Market Gene Therapy in CNS Disorder Forecast
  10.3.6 Australia Market Gene Therapy in CNS Disorder Forecast
10.4 Europe Gene Therapy in CNS Disorder Forecast by Country (2027-2032)
  10.4.1 Germany Market Gene Therapy in CNS Disorder Forecast
  10.4.2 France Market Gene Therapy in CNS Disorder Forecast
  10.4.3 UK Market Gene Therapy in CNS Disorder Forecast
  10.4.4 Italy Market Gene Therapy in CNS Disorder Forecast
  10.4.5 Russia Market Gene Therapy in CNS Disorder Forecast
10.5 Middle East & Africa Gene Therapy in CNS Disorder Forecast by Region (2027-2032)
  10.5.1 Egypt Market Gene Therapy in CNS Disorder Forecast
  10.5.2 South Africa Market Gene Therapy in CNS Disorder Forecast
  10.5.3 Israel Market Gene Therapy in CNS Disorder Forecast
  10.5.4 Turkey Market Gene Therapy in CNS Disorder Forecast
10.6 Global Gene Therapy in CNS Disorder Forecast by Type (2027-2032)
10.7 Global Gene Therapy in CNS Disorder Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Gene Therapy in CNS Disorder Forecast

11 KEY PLAYERS ANALYSIS

11.1 Voyager Therapeutics
  11.1.1 Voyager Therapeutics Company Information
  11.1.2 Voyager Therapeutics Gene Therapy in CNS Disorder Product Offered
  11.1.3 Voyager Therapeutics Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Voyager Therapeutics Main Business Overview
  11.1.5 Voyager Therapeutics Latest Developments
11.2 Spark Therapeutics
  11.2.1 Spark Therapeutics Company Information
  11.2.2 Spark Therapeutics Gene Therapy in CNS Disorder Product Offered
  11.2.3 Spark Therapeutics Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Spark Therapeutics Main Business Overview
  11.2.5 Spark Therapeutics Latest Developments
11.3 Novartis AG
  11.3.1 Novartis AG Company Information
  11.3.2 Novartis AG Gene Therapy in CNS Disorder Product Offered
  11.3.3 Novartis AG Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Novartis AG Main Business Overview
  11.3.5 Novartis AG Latest Developments
11.4 Bluebird Bio Inc.
  11.4.1 Bluebird Bio Inc. Company Information
  11.4.2 Bluebird Bio Inc. Gene Therapy in CNS Disorder Product Offered
  11.4.3 Bluebird Bio Inc. Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Bluebird Bio Inc. Main Business Overview
  11.4.5 Bluebird Bio Inc. Latest Developments
11.5 Biogen
  11.5.1 Biogen Company Information
  11.5.2 Biogen Gene Therapy in CNS Disorder Product Offered
  11.5.3 Biogen Gene Therapy in CNS Disorder Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Biogen Main Business Overview
  11.5.5 Biogen Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Gene Therapy in CNS Disorder Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Gene Therapy in CNS Disorder Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Viral Gene Therapy
Table 4. Major Players of Non-viral Gene Therapy
Table 5. Gene Therapy in CNS Disorder Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Gene Therapy in CNS Disorder Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Gene Therapy in CNS Disorder Market Size Market Share by Type (2021-2026)
Table 8. Gene Therapy in CNS Disorder Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Gene Therapy in CNS Disorder Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Gene Therapy in CNS Disorder Market Size Market Share by Application (2021-2026)
Table 11. Global Gene Therapy in CNS Disorder Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Gene Therapy in CNS Disorder Revenue Market Share by Player (2021-2026)
Table 13. Gene Therapy in CNS Disorder Key Players Head office and Products Offered
Table 14. Gene Therapy in CNS Disorder Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gene Therapy in CNS Disorder Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Gene Therapy in CNS Disorder Market Size Market Share by Region (2021-2026)
Table 19. Global Gene Therapy in CNS Disorder Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Gene Therapy in CNS Disorder Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Gene Therapy in CNS Disorder Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Gene Therapy in CNS Disorder Market Size Market Share by Country (2021-2026)
Table 23. Americas Gene Therapy in CNS Disorder Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Gene Therapy in CNS Disorder Market Size Market Share by Type (2021-2026)
Table 25. Americas Gene Therapy in CNS Disorder Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Gene Therapy in CNS Disorder Market Size Market Share by Application (2021-2026)
Table 27. APAC Gene Therapy in CNS Disorder Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Gene Therapy in CNS Disorder Market Size Market Share by Region (2021-2026)
Table 29. APAC Gene Therapy in CNS Disorder Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Gene Therapy in CNS Disorder Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Gene Therapy in CNS Disorder Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Gene Therapy in CNS Disorder Market Size Market Share by Country (2021-2026)
Table 33. Europe Gene Therapy in CNS Disorder Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Gene Therapy in CNS Disorder Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Gene Therapy in CNS Disorder Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Gene Therapy in CNS Disorder Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Gene Therapy in CNS Disorder Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Gene Therapy in CNS Disorder
Table 39. Key Market Challenges & Risks of Gene Therapy in CNS Disorder
Table 40. Key Industry Trends of Gene Therapy in CNS Disorder
Table 41. Global Gene Therapy in CNS Disorder Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Gene Therapy in CNS Disorder Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Gene Therapy in CNS Disorder Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Gene Therapy in CNS Disorder Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Voyager Therapeutics Details, Company Type, Gene Therapy in CNS Disorder Area Served and Its Competitors
Table 46. Voyager Therapeutics Gene Therapy in CNS Disorder Product Offered
Table 47. Voyager Therapeutics Gene Therapy in CNS Disorder Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Voyager Therapeutics Main Business
Table 49. Voyager Therapeutics Latest Developments
Table 50. Spark Therapeutics Details, Company Type, Gene Therapy in CNS Disorder Area Served and Its Competitors
Table 51. Spark Therapeutics Gene Therapy in CNS Disorder Product Offered
Table 52. Spark Therapeutics Gene Therapy in CNS Disorder Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Spark Therapeutics Main Business
Table 54. Spark Therapeutics Latest Developments
Table 55. Novartis AG Details, Company Type, Gene Therapy in CNS Disorder Area Served and Its Competitors
Table 56. Novartis AG Gene Therapy in CNS Disorder Product Offered
Table 57. Novartis AG Gene Therapy in CNS Disorder Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Novartis AG Main Business
Table 59. Novartis AG Latest Developments
Table 60. Bluebird Bio Inc. Details, Company Type, Gene Therapy in CNS Disorder Area Served and Its Competitors
Table 61. Bluebird Bio Inc. Gene Therapy in CNS Disorder Product Offered
Table 62. Bluebird Bio Inc. Gene Therapy in CNS Disorder Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Bluebird Bio Inc. Main Business
Table 64. Bluebird Bio Inc. Latest Developments
Table 65. Biogen Details, Company Type, Gene Therapy in CNS Disorder Area Served and Its Competitors
Table 66. Biogen Gene Therapy in CNS Disorder Product Offered
Table 67. Biogen Gene Therapy in CNS Disorder Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Biogen Main Business
Table 69. Biogen Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Gene Therapy in CNS Disorder Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy in CNS Disorder Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Gene Therapy in CNS Disorder Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Gene Therapy in CNS Disorder Sales Market Share by Country/Region (2025)
Figure 8. Gene Therapy in CNS Disorder Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Gene Therapy in CNS Disorder Market Size Market Share by Type in 2025
Figure 10. Gene Therapy in CNS Disorder in Alzheimer's Disease
Figure 11. Global Gene Therapy in CNS Disorder Market: Alzheimer's Disease (2021-2026) & ($ millions)
Figure 12. Gene Therapy in CNS Disorder in Huntington's Disease
Figure 13. Global Gene Therapy in CNS Disorder Market: Huntington's Disease (2021-2026) & ($ millions)
Figure 14. Gene Therapy in CNS Disorder in Parkinson's Disease
Figure 15. Global Gene Therapy in CNS Disorder Market: Parkinson's Disease (2021-2026) & ($ millions)
Figure 16. Gene Therapy in CNS Disorder in Batten Disease
Figure 17. Global Gene Therapy in CNS Disorder Market: Batten Disease (2021-2026) & ($ millions)
Figure 18. Global Gene Therapy in CNS Disorder Market Size Market Share by Application in 2025
Figure 19. Global Gene Therapy in CNS Disorder Revenue Market Share by Player in 2025
Figure 20. Global Gene Therapy in CNS Disorder Market Size Market Share by Region (2021-2026)
Figure 21. Americas Gene Therapy in CNS Disorder Market Size 2021-2026 ($ millions)
Figure 22. APAC Gene Therapy in CNS Disorder Market Size 2021-2026 ($ millions)
Figure 23. Europe Gene Therapy in CNS Disorder Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Gene Therapy in CNS Disorder Market Size 2021-2026 ($ millions)
Figure 25. Americas Gene Therapy in CNS Disorder Value Market Share by Country in 2025
Figure 26. United States Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Gene Therapy in CNS Disorder Market Size Market Share by Region in 2025
Figure 31. APAC Gene Therapy in CNS Disorder Market Size Market Share by Type (2021-2026)
Figure 32. APAC Gene Therapy in CNS Disorder Market Size Market Share by Application (2021-2026)
Figure 33. China Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 37. India Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Gene Therapy in CNS Disorder Market Size Market Share by Country in 2025
Figure 40. Europe Gene Therapy in CNS Disorder Market Size Market Share by Type (2021-2026)
Figure 41. Europe Gene Therapy in CNS Disorder Market Size Market Share by Application (2021-2026)
Figure 42. Germany Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 43. France Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Gene Therapy in CNS Disorder Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Gene Therapy in CNS Disorder Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Gene Therapy in CNS Disorder Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Gene Therapy in CNS Disorder Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 56. APAC Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 57. Europe Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 59. United States Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 60. Canada Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 61. Mexico Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 62. Brazil Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 63. China Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 64. Japan Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 65. Korea Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 67. India Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 68. Australia Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 69. Germany Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 70. France Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 71. UK Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 72. Italy Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 73. Russia Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 74. Egypt Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 75. South Africa Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 76. Israel Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 77. Turkey Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)
Figure 78. Global Gene Therapy in CNS Disorder Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Gene Therapy in CNS Disorder Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Gene Therapy in CNS Disorder Market Size 2027-2032 ($ millions)